$2.16
▲ +1.4% Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
Acrivon Therapeutics, Inc. (ACRV) Just Flashed Golden Cross Signal: Do You Buy?
Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
Overview
52-week range
$1.27
$3.56
39% of range
Avg surprise (last 3)
+4.7%
Avg reaction (last 2)
+1.2%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.43 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.49 | $-0.49 | 0.0% | +3.9% | +1.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.47 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.55 | $-0.57 | +3.5% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.51 | $-0.57 | +10.5% | — | +0.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.59 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.52 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.73 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.66 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.63 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.58 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-19M | $-20M | — | $-20M | $-23M | $-22M | — | $-25M |
| Net income | $-18M | $-19M | — | $-18M | $-21M | $-20M | — | $-22M |
| EPS (diluted) | $-0.43 | $-0.49 | — | $-0.47 | $-0.55 | $-0.51 | — | $-0.59 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $41M | $34M | $41M | $35M | $42M | $39M | $40M | $43M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $91M | $99M | $120M | $130M | $138M | $151M | $182M | $189M |
| Total assets | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $12M | $12M | $17M | $17M | $16M | $16M | $20M | $18M |
| Total equity | $87M | $96M | $113M | $129M | $143M | $160M | $177M | $197M |
Implied volatility — last 90 days
No IV snapshots yet for ACRV.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.